TGFB1 anticorps
-
- Antigène Voir toutes TGFB1 Anticorps
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Reactivité
- Humain, Souris, Rat, Boeuf (Vache), Mouton, Lapin, Vison
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp TGFB1 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Specificité
- Reacts with the dimeric (25 kDa) and monomeric (12.5 kDa) forms of TGF-beta under both non-reducing and reducing conditions respectively. This antibody recognizes both human platelet-derived and recombinant TGF-beta in ELISA
- Purification
- Protein G purified
- Immunogène
- TGF-beta from human platelets
- Clone
- TB21
- Isotype
- IgG1
- Top Product
- Discover our top product TGFB1 Anticorps primaire
-
-
- Indications d'application
- Neutralizing: This antibody neutralizes TGF-beta activity in vitro, in an inhibition assay of CCL/64 cell growth and neutralizes the growth promoting action of TGF-beta in the NRK-49F colony forming assay. The effect of microinjection of this antibody into one blastomere of two cell stage Xenopus embryos indicated that it was able to neutralize effectively the bioactivity of TGF-beta in vivo. IHC: This antibody has been used to demonstrate TGF-beta in ovine ovarian tissue and human breast carcinoma at a dilution of 1:1000. As a consequence of the intense staining of the erythrocytes it is possible to locate a single cell within the ovarian stroma making it useful in locating very fine capillary networks within tissue. Western Blotting: This antibody when used at an antibody concentration of 5--20 ng/mL will allow visualization of 100 ng/lane of TGF-beta.
- Commentaires
-
Myeloma, fusion partners: Sp2/0 Ag.14
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Whole IgG in 0.01M PBS, pH 7.0
-
-
Thrombospondin-1 is a major activator of TGF-beta1 in vivo." dans: Cell, Vol. 93, Issue 7, pp. 1159-70, (1998) (PubMed).
: "
-
Thrombospondin-1 is a major activator of TGF-beta1 in vivo." dans: Cell, Vol. 93, Issue 7, pp. 1159-70, (1998) (PubMed).
-
- Antigène
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
- Autre désignation
- TGF beta1 (TGFB1 Produits)
- Synonymes
- anticorps CED, anticorps DPD1, anticorps LAP, anticorps TGFB, anticorps TGFbeta, anticorps TGF-beta, anticorps TGF-BETA-1, anticorps TGF-beta5, anticorps ced, anticorps dpd1, anticorps lap, anticorps tgf-beta, anticorps tgfb, anticorps tgfb5, anticorps tgfbeta, anticorps TGF-beta1, anticorps TGFbeta1, anticorps Tgfb, anticorps Tgfb-1, anticorps ai39657, anticorps tgfb1, anticorps wu:fb13a07, anticorps xx:ai39657, anticorps TGFB1, anticorps csd, anticorps cdb1, anticorps cdg2, anticorps csd1, anticorps csd2, anticorps csd3, anticorps ebmd, anticorps lcd1, anticorps bigh3, anticorps cdgg1, anticorps betaig-h3, anticorps TGFB4, anticorps transforming growth factor beta 1, anticorps transforming growth factor beta-1, anticorps transforming growth factor beta 1 L homeolog, anticorps transforming growth factor, beta 1, anticorps transforming growth factor, beta 1a, anticorps transforming growth factor beta induced L homeolog, anticorps TGFB1, anticorps Tgfb1, anticorps tgfb1.L, anticorps tgfb1a, anticorps tgfbi.L
- Sujet
-
Synonyms:
Camurati Engelmann disease antibody,CED antibody,Diaphyseal dysplasia 1 progressive antibody,DPD1antibody,LAP antibody,Latency-associated peptide antibody,TGF beta 1 antibody,TGF beta antibody,TGF-beta-1antibody,TGF-beta-5 antibody,TGF-beta1 antibody,TGFB 1 antibody,TGFB antibody,Tgfb-1 antibody,TGFB1antibody,TGFB1_HUMAN antibody,TGFbeta antibody,TGFbeta1 antibody,Transforming Growth Factor beta 1antibody,Transforming growth factor, beta 1a antibody - UniProt
- P01137
- Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy, Cancer Immune Checkpoints
-